Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
contalgin forðatafla 100 mg
mundipharma a/s - morphini sulfas - forðatafla - 100 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
contalgin forðatafla 10 mg
mundipharma a/s - morphini sulfas - forðatafla - 10 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam medical valley munnholslausn 5 mg
medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 5 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
fluconazol krka hart hylki 200 mg
krka sverige ab - fluconazolum inn - hart hylki - 200 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
fluconazol krka hart hylki 50 mg
krka sverige ab - fluconazolum inn - hart hylki - 50 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam medical valley munnholslausn 10 mg
medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 10 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
metadon 2care4 tafla 10 mg
2care4 generics aps - methadonum hýdróklóríð - tafla - 10 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
metadon 2care4 tafla 20 mg
2care4 generics aps - methadonum hýdróklóríð - tafla - 20 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
metadon 2care4 tafla 5 mg
2care4 generics aps - methadonum hýdróklóríð - tafla - 5 mg
European Union -
Icelandic -
EMA (European Medicines Agency)
intuniv
takeda pharmaceuticals international ag ireland branch - guanfacín hýdróklóríð - attention deficit disorder með ofvirkni - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv verður að vera notað sem hluti af alhliða kynlÍf meðferð áætlun, venjulega þar á meðal sálfræðilega, mennta og félagslega mælist.